Management of Atrial Fibrillation with RVR, Cardiac Strain, Thrombus, CHF, and Pleural Effusion

Initial Assessment and Stabilization

• For patients with atrial fibrillation and signs of hemodynamic instability, the American College of Cardiology recommends immediate electrical cardioversion without waiting for anticoagulation 1, 2
• For hemodynamically stable patients, the American College of Cardiology recommends proceeding with rate control and anticoagulation 1

Rate Control Strategy

• The American College of Cardiology recommends administering a beta-blocker as first-line therapy to control heart rate at rest and during exercise for hemodynamically stable patients with AF and CHF 1, 3
• The target heart rate should be <110 bpm initially, with a goal of 60-80 bpm at rest 1

Anticoagulation Strategy

• The American College of Cardiology recommends immediate anticoagulation due to the documented thrombus in the left posterior TBL vein 1, 4
• The American College of Cardiology recommends beginning with intravenous unfractionated heparin and transitioning to oral anticoagulation with warfarin or a direct oral anticoagulant (DOAC) such as rivaroxaban 1, 3
• Anticoagulation should be continued for at least 3-4 weeks before considering cardioversion, and maintained for at least 4 weeks after if cardioversion is performed 1, 5

Heart Failure and Pleural Effusion Management

• The American College of Cardiology recommends administering intravenous diuretics to reduce fluid overload, improve CHF symptoms, and address the moderate right pleural effusion 6

Rhythm Control Considerations

• After initial rate control and anticoagulation, the American College of Cardiology recommends assessing whether rhythm control would benefit the patient 2
• If considering cardioversion, the American College of Cardiology recommends ensuring adequate anticoagulation for at least 3 weeks prior or performing TEE to rule out left atrial thrombus 1, 7

Common Pitfalls to Avoid

• The American College of Cardiology recommends avoiding digoxin as the sole agent for rate control in AF with RVR, especially in the acute setting 1, 9
• The American College of Cardiology recommends not discontinuing anticoagulation prematurely given the documented thrombus 1, 3
• The American College of Cardiology recommends not attempting cardioversion without adequate anticoagulation unless there is hemodynamic instability 1, 2

Long-term Management

• The American College of Cardiology recommends considering long-term rhythm control strategies if rate control alone is insufficient 2